140 related articles for article (PubMed ID: 2315705)
1. Cartilage degradative enzymes in human osteoarthritis: effect of a nonsteroidal antiinflammatory drug administered orally.
Vignon E; Mathieu P; Broquet P; Louisot P; Richard M
Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 1):26-9. PubMed ID: 2315705
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase A2 activity in human osteoarthritic cartilage.
Vignon E; Mathieu P; Louisot P; Vilamitjana J; Harmand MF; Richard M
J Rheumatol Suppl; 1989 Aug; 18():35-8. PubMed ID: 2553968
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of nonsteroidal antiinflammatory drugs.
Brandt KD
J Rheumatol Suppl; 1991 Feb; 27():120-1. PubMed ID: 2027109
[TBL] [Abstract][Full Text] [Related]
4. Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity.
Fernandes JC; Caron JP; Martel-Pelletier J; Jovanovic D; Mineau F; Tardif G; Otterness IG; Pelletier JP
Arthritis Rheum; 1997 Feb; 40(2):284-94. PubMed ID: 9041940
[TBL] [Abstract][Full Text] [Related]
5. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of nonsteroidal antiinflammatory drugs on proteoglycanase and collagenase activity in human osteoarthritic cartilage.
Vignon E; Mathieu P; Louisot P; Richard M
Arthritis Rheum; 1991 Oct; 34(10):1332-5. PubMed ID: 1657006
[TBL] [Abstract][Full Text] [Related]
7. Effects of tenidap on canine experimental osteoarthritis. I. Morphologic and metalloprotease analysis.
Fernandes JC; Martel-Pelletier J; Otterness IG; Lopez-Anaya A; Mineau F; Tardif G; Pelletier JP
Arthritis Rheum; 1995 Sep; 38(9):1290-303. PubMed ID: 7575725
[TBL] [Abstract][Full Text] [Related]
8. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID.
Pelletier JP; Martel-Pelletier J
J Rheumatol Suppl; 1989 Aug; 18():19-27. PubMed ID: 2553967
[TBL] [Abstract][Full Text] [Related]
9. Study of the effect of a glycosaminoglycan-peptide complex on the degradative enzyme activities in human osteoarthritic cartilage.
Vignon E; Martin A; Mathieu P; Conrozier T; Louisot P; Richard M
Clin Rheumatol; 1990 Sep; 9(3):383-8. PubMed ID: 2261738
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage.
Pelletier JP; Cloutier JM; Martel-Pelletier J
J Rheumatol; 1989 May; 16(5):646-55. PubMed ID: 2754669
[TBL] [Abstract][Full Text] [Related]
11. Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study.
Mastbergen SC; Bijlsma JW; Lafeber FP
Osteoarthritis Cartilage; 2005 Jun; 13(6):519-26. PubMed ID: 15922186
[TBL] [Abstract][Full Text] [Related]
12. Effects of SKI 306X, a new herbal agent, on proteoglycan degradation in cartilage explant culture and collagenase-induced rabbit osteoarthritis model.
Choi JH; Choi JH; Kim DY; Yoon JH; Youn HY; Yi JB; Rhee HI; Ryu KH; Jung K; Han CK; Kwak WJ; Cho YB
Osteoarthritis Cartilage; 2002 Jun; 10(6):471-8. PubMed ID: 12056850
[TBL] [Abstract][Full Text] [Related]
13. [Cartilage changes in arthrosis--do non-steroidal antiphlogistics have positive or negative effects?].
Ostensen M
Tidsskr Nor Laegeforen; 1991 Mar; 111(7):838-40. PubMed ID: 2020951
[TBL] [Abstract][Full Text] [Related]
14. Clinical aspects of chrondroprotection.
Huskisson EC
Semin Arthritis Rheum; 1990 Feb; 19(4 Suppl 1):30-2. PubMed ID: 2315706
[No Abstract] [Full Text] [Related]
15. Treatment of osteoarthritis with tiaprofenic acid: biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model.
Howell DS; Pita JC; Muller FJ; Manicourt DH; Altman RD
J Rheumatol Suppl; 1991 Feb; 27():138-42. PubMed ID: 2027115
[TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal antiinflammatory drugs in treatment of osteoarthritis.
Brandt KD; Slowman-Kovacs S
Clin Orthop Relat Res; 1986 Dec; (213):84-91. PubMed ID: 3780106
[TBL] [Abstract][Full Text] [Related]
17. Biochemical aspects of osteoarthritis.
Howell DS
Scand J Rheumatol Suppl; 1990; 81():5-7. PubMed ID: 2305220
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
Shinmei M; Kikuchi T; Masuda K; Shimomura Y
Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
[TBL] [Abstract][Full Text] [Related]
19. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
20. Effects of nimesulide and naproxen on the degradation and metalloprotease synthesis of human osteoarthritic cartilage.
Pelletier JP; Martel-Pelletier J
Drugs; 1993; 46 Suppl 1():34-9. PubMed ID: 7506192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
